Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications

Breaking the Phalanx: Overcoming Bacterial Drug Resistance with Quorum Sensing Inhibitors that Enhance Therapeutic Activity of Antibiotics.

Breaking the Phalanx: Overcoming Bacterial Drug Resistance with Quorum Sensing Inhibitors that Enhance Therapeutic Activity of Antibiotics.

Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025

Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis.

Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis.

Journal: ACS pharmacology & translational science
Published: January 15, 2025

Impact of treatment on quality of life in neuroendocrine neoplasm survivors.

Impact of treatment on quality of life in neuroendocrine neoplasm survivors.

Journal: Endocrine-related cancer
Published: November 10, 2024

Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Administrative Data.

Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Administrative Data.

Journal: Advances in therapy
Published: October 25, 2024

Telotristat ethyl affects tumour-fibroblast crosstalk in small intestinal neuroendocrine tumours.

Telotristat ethyl affects tumour-fibroblast crosstalk in small intestinal neuroendocrine tumours.

Journal: Journal of neuroendocrinology
Published: October 08, 2024

Efficacy of Racecadotril in a Patient Affected by a Therapy-Refractory VIPoma and Carcinoid Syndrome.

Efficacy of Racecadotril in a Patient Affected by a Therapy-Refractory VIPoma and Carcinoid Syndrome.

Journal: JCEM case reports
Published: July 11, 2024

Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models.

Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models.

Journal: Journal of cellular and molecular medicine
Published: March 28, 2024

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?

Journal: International journal of molecular sciences
Published: November 29, 2023

Use of perioperative telotristat in a patient with carcinoid heart disease.

Use of perioperative telotristat in a patient with carcinoid heart disease.

Journal: Endocrinology, diabetes & metabolism case reports
Published: June 01, 2023

Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.

Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma.

Journal: Oncoimmunology
Published: May 01, 2023

Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivo.

Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivo.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2023

The role of serotonin inhibition within the treatment of carcinoid syndrome.

The role of serotonin inhibition within the treatment of carcinoid syndrome.

Journal: Endocrine oncology (Bristol, England)
Published: March 20, 2023
Showing 1-12 of 103

Last Updated: 10/31/2025